How to recognise a Behçet's ulcer from other types of oral ulceration? Defining Behçet's ulceration by an International Delphi Consultation.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 06 12 2022
accepted: 27 03 2023
medline: 31 10 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: ppublish

Résumé

To define the clinical characteristics of oral ulceration (OU) in Behçet's disease (BD), to allow differentiation from other causes of OU, including aphthous ulcers, by an International Delphi consultation. To develop a clinical guideline on how to recognise BD ulcers. Round 1. 40 clinical images of OU in BD, recurrent aphthous stomatitis (RAS), inflammatory bowel disease (IBD) and mucous membrane pemphigoid (MMP) were shown. Participants answered, independently, which images would be consistent with a BD ulcer. Round 2. The results from marking independently were shown. The panel remarked the questions through iteration process. The images not agreed to be a possible BD ulcer were discarded. Round 3. 10 clinical descriptors that may define BD ulcers were suggested. Participants ranked the level of importance for each descriptor on each image presented. Round 4. Participants re-ranked their level of agreement for each descriptor through iteration process. Whether the clinical pictures would be different from RAS was also explored. A final agreement was reached. This study has shown clear differentiation between BD, IBD and MMP ulcers when defining them by phenotype through clinical images only. On the other hand, no differentiation between RAS and BD ulcers was found. The most important clinical descriptors that define BD ulcers have been agreed. New clinical guidance for Health Care Professionals (HCP) on how to recognise a BD ulcer has been proposed. This should elucidate an earlier diagnosis, quicker access to treatment and control of the disease enhancing patient's quality of life.

Identifiants

pubmed: 37902271
pii: 19471
doi: 10.55563/clinexprheumatol/joeacu
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2048-2055

Investigateurs

Gulen Hatemi (G)
Dongsik Bang (D)
Cheyda Chams-Davatchi (C)
Yusuf Yazici (Y)
Rifkiye Kucukoglu (R)
Gonca Mumcu (G)
Johannes Nowatzky (J)
David Saadoun (D)
Bahram Bodaghi (B)
Andrea Richards (A)
Bijay Rajlawat (B)
J Gabriel Ovalles-Bonilla (JG)
Jon Higham (J)
Raj Ariyaratnam (R)
Rui Albuquerque (R)

Auteurs

Ana Poveda-Gallego (A)

Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham; School of Dentistry, Institute of Medical and Dental Sciences, College of Medical and Dental Sciences, University of Birmingham; and Birmingham Dental Hospital, Birmingham Community Health Foundation Trust, Birmingham, UK. p.g.ana@bham.ac.uk.

Iain Chapple (I)

School of Dentistry, Institute of Medical and Dental Sciences, College of Medical and Dental Sciences, University of Birmingham; Birmingham's NIHR BRC in Inflammation Research, University of Birmingham; and Birmingham Dental Hospital, Birmingham Community Health Foundation Trust, Birmingham, UK.

Marietta Iacucci (M)

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, UK.

John Hamburger (J)

School of Dentistry, Institute of Medical and Dental Sciences, College of Medical and Dental Sciences, University of Birmingham, UK.

Philip I Murray (PI)

Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, and Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, UK.

Saaeha Rauz (S)

Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, and Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, UK.

Graham R Wallace (GR)

Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH